Skip to content

    Core Laboratories Inc. /DE/ (CLB) stock price & financials

    View CLB earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+11.0% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $134.40M
    $129.24M
    $123.58M
    $130.16M
    $134.52M
    +0.1%
    $138.25M
    +7.0%
    $121.80M
    -1.4%
    $124.61M
    -4.3%
    Stable
    Operating Profit
    $19.80M
    $14.17M
    $4.42M
    $15.29M
    $20.93M
    +5.7%
    $15.83M
    +11.7%
    $1.89M
    -57.3%
    $9.15M
    -40.2%
    Weakening
    Net Profit
    $11.74M
    $7.40M
    -$154.0K
    $10.64M
    $14.24M
    +21.2%
    $4.95M
    -33.2%
    -$789.0K
    -412.3%
    $5.96M
    -44.0%
    Weakening
    EPS
    $0.25
    $0.00
    $0.23
    $0.31
    +24.0%
    $-0.02
    $0.13
    -43.5%
    Weakening
    Other Income
    Interest
    $3.11M
    $2.63M
    $2.60M
    $2.71M
    $2.65M
    -14.7%
    $2.61M
    -0.8%
    $2.89M
    +11.1%
    $2.85M
    +5.0%
    Strengthening
    Depreciation
    Profit before Tax
    $16.70M
    $11.54M
    $1.81M
    $12.58M
    $18.28M
    +9.5%
    $13.22M
    +14.5%
    -$1.00M
    -155.3%
    $6.30M
    -49.9%
    Weakening
    MarginsOPM
    14.7%
    11.0%
    3.6%
    11.8%
    15.6%
    +5.6%
    11.4%
    +4.4%
    1.6%
    -56.6%
    7.3%
    -37.5%
    Weakening
    Tax
    28.1%
    35.3%
    96.2%
    15.2%
    20.5%
    -26.9%
    61.2%
    +73.4%
    25.0%
    -74.0%
    8.0%
    -47.1%
    Weakening
    ReturnsROIC
    6.6%
    4.2%
    -0.1%
    6.0%
    8.0%
    +21.2%
    2.8%
    -33.2%
    -0.4%
    -412.3%
    3.4%
    -44.0%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$17.70M$15.43M$15.12M$19.16M$22.70M$22.73M
    Short-Term Investments
    Total Current Assets$211.70M$223.14M$221.33M$214.66M$214.36M
    Net PP&E$110.95M$157.41M$153.47M$153.55M$153.79M$153.26M
    Goodwill$99.44M$99.44M$99.44M$105.79M$105.80M
    Intangibles$7.48M$6.93M$6.40M$7.12M$6.75M
    Total Assets$580.85M$578.35M$586.39M$585.13M$584.01M$586.78M
    LiabilitiesTotal Current Liabilities$103.14M$88.10M$102.44M$106.02M$101.05M
    Short-Term Debt
    Long-Term Debt$172.39M$163.13M$126.11M$110.25M$113.86M
    Long-Term Leases$38.30M$42.08M$43.34M$42.31M$39.31M
    Total Liabilities$419.85M$394.82M$362.01M$332.81M$311.80M$308.01M
    EquityCommon Stock & APIC$1.19M$469.0K$470.0K$470.0K$470.0K
    Retained Earnings$85.95M$120.76M$144.86M$172.66M$176.91M
    Total Equity$161.00M$184.26M$224.81M$246.57M$265.99M$272.67M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating$36.58M$24.96M$24.79M$56.39M$37.03M$28.22M
    Cash from Investing-$10.22M-$3.86M-$6.65M-$6.39M-$2.23M-$8.68M
    Cash from Financing-$22.46M-$23.38M-$18.45M-$45.96M-$31.25M-$27.99M
    SummaryCapital Expenditure-$13.54M-$10.22M-$10.58M-$11.89M-$11.21M-$13.09M
    Free Cash Flow$23.04M$14.74M$14.21M$44.50M$25.82M$15.14M
    FCF Margin4.9%3.0%2.8%8.5%4.9%2.9%

    Ratios